Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Optimal therapy for children with high risk ALL

Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA
Optimal therapy for children with high risk ALL ( Dr Eric Larsen - Maine Children’s Cancer Program, Portland, USA )
23 Jun 2011

Olaparib maintenance therapy for ovarian cancer and updates from ICON7

Prof Jonathan Ledermann - UCL Cancer Institute, London, UK
Olaparib maintenance therapy for ovarian cancer and updates from ICON7 ( Prof Jonathan Ledermann - UCL Cancer Institute, London, UK )
22 Jun 2011

New oncogene target for breast cancer: LMTK3

Prof Justin Stebbing - Imperial College London, UK
New oncogene target for breast cancer: LMTK3 ( Prof Justin Stebbing - Imperial College London, UK )
22 Jun 2011

Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma

Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011

Advances in breast cancer research from ASCO 2011

Dr David Miles - Mount Vernon Hospital, London, UK
Advances in breast cancer research from ASCO 2011 ( Dr David Miles - Mount Vernon Hospital, London, UK )
20 Jun 2011

Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer

Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer ( Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011

ASCO 2011 highlights

Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011

Advances in understanding the genetic basis of kidney cancer

Prof Tim Eisen - Cambridge Cancer Centre, UK
Advances in understanding the genetic basis of kidney cancer ( Prof Tim Eisen - Cambridge Cancer Centre, UK )
3 Jun 2011

The future of medicine: personalised

Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011

New models in interdisciplinary, translational and clinical research

Prof Alan Nelson - Arizona State University Biodesign Institute, Tempe, USA
New models in interdisciplinary, translational and clinical research ( Prof Alan Nelson - Arizona State University Biodesign Institute, Tempe, USA )
2 Jun 2011

Renal cancer 2011: novel targets

Prof Michael Atkins - Harvard Cancer Centre, Boston, USA
Renal cancer 2011: novel targets ( Prof Michael Atkins - Harvard Cancer Centre, Boston, USA )
2 Jun 2011

New agents for the treatment of advanced renal cancer

Prof Sergio Bracarda - Ospedale San Maria della Misericordia, Perugia, Italy
New agents for the treatment of advanced renal cancer ( Prof Sergio Bracarda - Ospedale San Maria della Misericordia, Perugia, Italy )
2 Jun 2011